|
|
|
|
LEADER |
009270000a22003010004500 |
020 |
|
|
|a 1-4020-0706-X
|
082 |
|
|
|a 616.994 065 1 P3
|
100 |
|
|
|a Oldham, Robert K; Editor
|
245 |
|
|
|a Principles of cancer biotherapy
|
250 |
|
|
|a Ed.4
|
260 |
|
|
|a Dordrecht, Kluwer Academic Publishers
|
260 |
|
|
|c 2003
|
460 |
|
|
|a xii,684p
|
465 |
|
|
|a USD215.00
|
500 |
|
|
|a ed by Robert K Oldham
|
500 |
|
|
|a Includes bibliographical references and index
|
650 |
|
|
|a Antineoplastic agents
|
650 |
|
|
|a Biological products
|
650 |
|
|
|a Biological response modifiers
|
650 |
|
|
|a Cancer
|
650 |
|
|
|a Immunology
|
650 |
|
|
|a Immunotherapy
|
650 |
|
|
|a Neoplasms
|
650 |
|
|
|a Therapeutic use
|
650 |
|
|
|a Therapy
|
942 |
|
|
|c BK
|
999 |
|
|
|c 34129
|d 34129
|
952 |
|
|
|0 0
|1 0
|4 0
|6 616_994000000000000_065_1_P3
|7 0
|8 ENG
|9 34439
|a MGUL
|b MGUL
|d 2013-07-16
|e USD215.00
|l 1
|o 616.994 065 1 P3
|p 34600
|r 2014-09-16
|s 2014-04-01
|w 2013-07-16
|y BK
|